Effects of pre-treatment with aflatoxin on a second aflatoxin treatment in guinea pigs
โ Scribed by W. M. Peden; J. L. Richard; J. R. Thurston; J. L. Sacks
- Book ID
- 104772961
- Publisher
- Springer Netherlands
- Year
- 1987
- Tongue
- English
- Weight
- 606 KB
- Volume
- 99
- Category
- Article
- ISSN
- 0301-486X
No coin nor oath required. For personal study only.
โฆ Synopsis
Two-hundred guinea pigs, weighing approximately 500 grams each, were placed in 8 groups, 4 of which received 20 micrograms/kg/day of partially purified aflatoxin for 7 days, followed by a 7 day recovery period. Paired groups then received 0, 20, 35 or 50 micrograms/kg/day of partially purified aflatoxin for 21 days. Animals were sacrificed periodically from all groups and blood was drawn for chemical and immunologic analysis. Weight gains were recorded and histopathologic studies were done on all animals. Pretreatment did not protect guinea pigs from a second exposure, and in fact enhanced mortality and liver toxicity as determined by histopathology. Serum chemistries and immunologic parameters of guinea pigs dosed twice were less conclusive, as neither high nor low doses differed from guinea pigs treated once. Glycocholic acid concentrations were more sensitive than traditional enzymes (aspartate and alanine amino transferase, alkaline phosphatase) for indicating hepatotoxicity.
๐ SIMILAR VOLUMES
Cyclopiazonic acid (CPA) and aflatoxin are known sometimes to coexist in nature but little is known of possible biological interaction in mammals that consume mixtures of these two mycotoxins. Guinea pigs were dosed orally with CPA (2.2 mg/kg) or aflatoxin (0.045 mg B1/kg ) singly or in combination.
Intermittent haloperidol treatment in guinea pigs caused an increase in the behavioral response to apomorphine and an increase oin 3H-spiroperidol binding in the striatum to the same degree as continual haloperidol treatment. These results do not support the claim that drug holidays can reduce the i